Tumor Biopsy Guidelines

Introduction to Tumor Biopsy

• The American College of Radiology recommends that tumor seeding risk after liver biopsy is only 2.7%, with median time to seeding of 17 months, and does not affect overall survival 1, 2, 3, 4
• The European Association for the Study of the Liver states that imaging-based diagnosis using multiphasic CT or MRI has 91-95% accuracy for HCC diagnosis in cirrhotic patients 5
• The American College of Radiology suggests that bleeding complications from liver biopsy are mild in 3-4% and severe requiring transfusion in only 0.5% 1, 2, 3, 4

Tumors to Resect Without Biopsy

• The American Association for the Study of Liver Diseases recommends that HCC with classic imaging features can be diagnosed without biopsy and proceed directly to treatment in cirrhotic liver 3, 4
• The European Society of Medical Oncology states that small, symptomatic gastric GISTs causing bleeding may undergo excision biopsy when percutaneous biopsy is technically difficult 6

Tumors Where Biopsy Is Safe and Recommended

• The National Comprehensive Cancer Network recommends that core needle biopsy is the preferred diagnostic method for bone tumors, with lower complication rates than open biopsy 7
• The British Journal of Cancer suggests that preoperative biopsy is safe and increasingly recommended for GIST, especially for large/complex tumors requiring major resection to guide neoadjuvant therapy 6
• The American College of Radiology recommends that percutaneous core needle biopsy is strongly preferred over open biopsy for soft tissue sarcomas, with a significantly lower contamination rate 7

Key Risk Mitigation Strategies

• The American College of Radiology recommends using coaxial needle technique for liver biopsies to significantly reduce tumor seeding risk 8
• The European Association for the Study of the Liver states that performing biopsies at high-volume centers with expertise can reduce risks 1, 2, 3, 4
• The National Comprehensive Cancer Network suggests that ensuring biopsy tract is within planned resection field for bone/soft tissue tumors can reduce contamination risk 7

Bleeding Risk Management

• The American College of Radiology recommends that hypervascular liver lesions carry 9-12% bleeding risk, and most bleeding is mild, with severe bleeding requiring transfusion in only 0.5% 9, 5, 10, 1, 2, 3, 4
• The European Society of Medical Oncology states that considering CEUS guidance can increase technical success from 74% to 100% and reduce bleeding risk 9, 5